81 related articles for article (PubMed ID: 2844213)
1. Varicella serology in institutional exposure management.
Sulkes SB; Quinn EA
Am J Ment Retard; 1988 Sep; 93(2):113-7. PubMed ID: 2844213
[TBL] [Abstract][Full Text] [Related]
2. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.
Steele RW; Coleman MA; Fiser M; Bradsher RW
Pediatrics; 1982 Oct; 70(4):604-8. PubMed ID: 6289236
[TBL] [Abstract][Full Text] [Related]
3. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test.
Gershon AA; Krugman S
Pediatrics; 1975 Dec; 56(6):1005-8. PubMed ID: 172853
[TBL] [Abstract][Full Text] [Related]
5. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
6. What's new in chickenpox (varicella-zoster) infection?
Gershon AA
West J Med; 1993 Feb; 158(2):180. PubMed ID: 8382001
[No Abstract] [Full Text] [Related]
7. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
[TBL] [Abstract][Full Text] [Related]
8. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
9. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
[TBL] [Abstract][Full Text] [Related]
11. Pox in the docks: varicella outbreak in an Australian prison system.
Levy MH; Quilty S; Young LC; Hunt W; Matthews R; Robertson PW
Public Health; 2003 Nov; 117(6):446-51. PubMed ID: 14522161
[TBL] [Abstract][Full Text] [Related]
12. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
13. Difficulty in determining varicella-zoster immune status in pregnant women.
Le CT; Lipson M
Pediatr Infect Dis J; 1989 Sep; 8(9):650-1. PubMed ID: 2552391
[No Abstract] [Full Text] [Related]
14. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
[No Abstract] [Full Text] [Related]
15. Indirect haemagglutination reaction with varicella-zoster virus antigen.
Trlifajová J; Pokorný J; Ryba M; Strízová V
J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
[No Abstract] [Full Text] [Related]
16. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
[No Abstract] [Full Text] [Related]
17. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
Ueda K; Tokugawa K; Nakashima F; Takahashi M
Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir prophylaxis of varicella after household exposure.
Huang YC; Lin TY; Chiu CH
Pediatr Infect Dis J; 1995 Feb; 14(2):152-4. PubMed ID: 7746701
[No Abstract] [Full Text] [Related]
19. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
Nyerges G; Mészner Z; Simon M
Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of varicella in immunocompromised children. Clinical and serological evaluation of specific anti-varicella-zoster immunoglobulins].
Macchia P; Abadessa A; Nardi M; Consolini R; Conaldi PG; Bendinelli M
Minerva Pediatr; 1984 Nov; 36(21):1053-7. PubMed ID: 6099463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
